UFO Moviez India Limited (the “Company”) will open on April 28, 2015, a public issue of equity shares of face value Rs. 10 each (“Equity Shares”) for cash, at a price per Equity Share (including a Share Premium) aggregating to Rs. 6,000 million (the “Offer”) through an Offer for Sale by 3i Research (Mauritius) Limited (“3i RESEARCH”), P5 Asia Holding Investments (Mauritius) Limited (“P5”), Sanjay Gaikwad (Managing Director), Narendra Hete, Valuable Media Limited, Valuable Technologies Limited, Raaja Kanwar, Prafulla Vaidya, Uday Gaikwad, Rakesh Gupta, Amit K. Mehta, Amit S. Shelar, Ashish Sadanand Malushte, Daniyal Appa Parab, Deepak Ranjan, Dheerendra Singh Muchhal, K. Suvarna, Kapil Kumar Agarwal (Joint Managing Director), Ketan Natwarlal Pithadia, Mitalee V. Patel, Mukesh Shanker Sherigar, Nitin Lionel Monteiro, Nitin Nohani, Prashant S. Keluskar, Pravin Ramdas Vaje, Rajendra Laxman Gaikwad, Rajesh B. Mishra, Ravi Sukhadeo Nakhale, Samir Shantaram Surve, Sanjay Pardeshi Chavan, Sudalaimani Konar, Sudhir Vittal Shetty, Swapnil C. Borkar, Vikram Machaiah and Vishnu Vithalbhai Patel (together the “Selling Shareholders”).
The Price Band is fixed from Rs. 615 to Rs. 625 per Equity Share. The Anchor Investor Bidding Date shall be on Monday, April 27, 2015 - one Working Day prior to the Offer Opening Date. The Bid/ Issue will close on April 30, 2015. The minimum Bid Lot is 24 Equity Shares and in multiples of 24 Equity Shares thereafter.
The Global Co-ordinators and Book Running Lead Managers (or collectively “Managers”) to the Issue are Axis Capital Limited and Citigroup Global Markets India Private Limited.
The Equity Shares offered through the Red Herring Prospectus are proposed to be listed on BSE and NSE.
In terms of Rule 19(2)(b)(i) of the Securities Contracts (Regulation) Rules, 1957, as amended (“SCRR”) read with Regulation 41 of the ICDR Regulations, this is an offer for at least 25% of the post-Offer capital and is being made through the Book Building Process, wherein 50% of the Offer shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (“QIBs”). Provided that our Company, 3i Research, P5 and the Promoter Selling Shareholders, in consultation with the Managers, may allocate up to 60% of the QIB Category to Anchor Investors on a discretionary basis out of which one‑third shall be reserved for domestic Mutual Funds only subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price.
In the event of under‑subscription in the Anchor Investor Portion, the remaining Equity Shares shall be added to the Net QIB Category. 5% of the Net QIB Category shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the Net QIB Category shall be available for allocation on a proportionate basis to all QIBs, including Mutual Funds, subject to valid Bids being received at or above the Offer Price. Further, not less than 15% of the Offer shall be available for allocation on a proportionate basis to Non‑Institutional Investors and not less than 35% of the Offer shall be available for allocation, in accordance with the ICDR Regulations, to Retail Individual Investors, subject to valid Bids being received at or above the Offer Price. All investors, other than Anchor Investors, can participate in the Offer through the Applications Supported by Blocked Amount (“ASBA”) process by providing the details of their respective bank accounts in which the corresponding Bid Amount will be blocked by the Self Certified Syndicate Banks (“SCSBs”). However, QIBs (excluding Anchor Investors) and Non-Institutional Investors are mandatorily required to submit their Bids by way of ASBA only.